Is increased screening and early antiretroviral treatment for HIV-1 worth the investment? An analysis of the public health and economic impact of improvement in the UK.

Brogan, A J

Is increased screening and early antiretroviral treatment for HIV-1 worth the investment? An analysis of the public health and economic impact of improvement in the UK. [electronic resource] - HIV medicine 11 2019 - 668-680 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1468-1293

10.1111/hiv.12788 doi


Adult
Cost-Benefit Analysis
Female
HIV Infections--diagnosis
HIV-1
Health Care Costs
Humans
Male
Markov Chains
Mass Screening--economics
Middle Aged
Public Health
Quality-Adjusted Life Years
United Kingdom